3B BLACKBIO DX LTD. (3BBLACKBIO)

NSE: ₹1,126.90
BSE: ₹1,129.75
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31, 2026

2026-06-03 18:32:39
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio Recording of Analysts/Investors Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 2026

2026-06-01 18:25:00
2026-05-30 15:24:31
2026-05-29 16:13:18
Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended On 31St March, 2026

Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March, 2026

2026-05-29 15:57:54
Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting held today i.e. 29th May, 2026

2026-05-29 15:43:27
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Earning Concall under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.

2026-05-26 16:53:34
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended 31st March, 2026

2026-05-22 17:34:44
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For Quarter / Financial Year Ended 31St March, 2026 And To Discuss Matter Of Recommendation Of Dividend ,If Any, For Financial Year Ended 31St March, 2026

the Audited Financial Results (Standalone and Consolidated) for the quarter / financial year ended 31st March, 2026 and to discuss the matter of recommendation of dividend ,if any, for the financial year ended 31st March, 2026.

2026-05-20 15:27:38

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 2.46 18.57 16.96 21.99 17.51 26.57 23.43 23.02 20.36 27.91 24.38 24.63
YOY Revenue Growth % 6.81% 372.61% 594.35% 562.45% 610.25% 43.11% 38.16% 4.7% 16.28% 5.04% 4.04% 7%
Other Income 0.39 2.75 2.47 4.15 3.68 3.43 3.01 4.91 4.31 3.91 4.63 1.30
Total Income 2.86 21.31 19.42 26.13 21.18 30.00 26.44 27.93 24.67 31.82 29.01 25.93
Total Expenses + 2.54 10.16 7.58 12.14 7.39 11.73 8.71 13.79 8.99 12.30 10.15 13.65
Cost of Materials Consumed 1.70 6.09 4.12 5.52 4.97 7.26 5.70 6.82 5.20 6.83 5.63 5.79
Employee Benefit Expense 0.46 1.42 1.23 1.41 1.29 1.81 1.45 1.66 1.49 2.16 1.68 2.26
Other Expenses 0.38 1.81 2.00 4.88 1.36 2.27 1.80 4.64 2.14 3.02 2.78 5.00
Operating Profit -0.07 8.40 9.38 9.85 10.11 14.84 14.72 9.23 11.37 15.61 14.23 10.98
OPM % -2.9% 45.3% 55.3% 44.8% 57.8% 55.8% 62.8% 40.1% 55.8% 55.9% 58.4% 44.6%
Profit Before Tax + 0.32 11.15 11.84 14.00 13.79 18.27 17.73 14.14 15.68 19.52 18.86 12.29
Tax Expense 0.08 2.67 2.64 4.94 3.06 4.13 4.28 4.90 3.22 4.58 4.40 4.84
Tax % 25.2% 24% 22.2% 35.3% 22.2% 22.6% 24.2% 34.6% 20.5% 23.5% 23.3% 39.4%
Profit After Tax 0.24 8.48 9.21 9.06 10.73 14.14 13.45 9.24 12.46 14.94 14.46 7.45
EPS (Basic) 0.32 9.90 10.75 10.57 12.53 16.51 15.70 10.79 14.54 17.44 16.88 8.69

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 97.28 90.53 70.72 12.00 15.52 14.36
YOY Revenue Growth % 7.45% 28% 489.49% -22.71% 8.12% -
Other Income 14.16 15.03 12.32 4.09 10.09 3.72
Total Income 111.44 105.56 83.04 16.08 25.62 18.08
Total Expenses + 45.08 41.63 36.60 13.43 17.15 16.00
Cost of Materials Consumed 23.45 24.76 19.81 8.20 10.02 9.09
Employee Benefit Expense 7.58 6.21 5.14 1.84 1.58 1.64
Other Expenses 12.95 10.07 10.32 2.38 3.20 2.66
Operating Profit 52.19 48.90 34.13 -1.44 -1.63 -1.64
OPM % 53.7% 54% 48.3% -12% -10.5% -11.4%
Profit Before Exceptional 66.36 63.93 46.44 2.65 8.46 2.08
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 66.36 63.93 46.44 2.65 8.46 2.08
Tax Expense 17.04 16.37 12.23 0.49 0.46 0.37
Tax % 25.7% 25.6% 26.3% 18.5% 5.4% 17.6%
Profit After Tax 49.32 47.56 34.21 2.16 8.01 1.72
EPS (Basic) 57.56 55.51 39.93 2.88 10.67 2.29

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 198.02 173.07 142.20 6.92 7.20 5.97
Property, Plant & Equipment 6.80 6.37 6.53 3.00 3.23 1.97
Capital Work in Progress 0.00 0.00 0.00 0.09 0.11 0.13
Non-Current Investments 188.10 166.70 127.70 3.60 3.60 3.60
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 152.36 124.05 107.62 22.94 24.40 22.92
Inventories 6.57 8.14 0.00 3.04 2.66 2.71
Trade Receivables 43.20 35.18 36.47 13.70 14.35 14.09
Cash and Cash Equivalents 16.80 6.27 6.35 0.67 1.55 1.44
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 319.02 272.79 227.78 24.22 23.93 22.65
Equity Share Capital 8.57 8.57 8.57 7.49 7.49 7.49
Other Equity 310.45 264.22 219.21 16.73 16.44 15.16
Non-Current Liabilities 6.70 6.13 5.02 1.80 1.75 1.64
Current Liabilities 24.66 18.21 17.02 3.84 5.93 4.60
Total Liabilities 31.36 24.33 22.04 5.64 7.67 6.23

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 42.82 44.47 28.47 1.65 7.98 2.79
Cash from Investing Activities -19.80 -33.64 -20.32 -0.02 -1.52 -0.17
Cash from Financing Activities -6.55 -3.07 -3.62 -2.57 -6.31 -1.59
Net Increase/Decrease in Cash 16.47 7.76 4.53 -0.95 0.14 1.02